Evidence map›Paper›PMID 27090639›Full record

ArticleMolecular and cellular biology2016

Cystatin E/M Suppresses Tumor Cell Growth through Cytoplasmic Retention of NF-κB.

Hendrick Soh, Natarajan Venkatesan, Mysore S Veena, Sandhiya Ravichandran, Alborz Zinabadi, Saroj K Basak, Kislay Parvatiyar, Meera Srivastava, Li-Jung Liang, David W Gjertson and 3 more

Abstract read
In one paragraph

Article in Molecular and cellular biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Hendrick SohDivision of General Surgery, Department of Surgery, VAGLAHS/David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Natarajan VenkatesanDivision of General Surgery, Department of Surgery, VAGLAHS/David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Mysore S VeenaDepartment of Medicine, VAGLAHS/David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Sandhiya RavichandranDivision of General Surgery, Department of Surgery, VAGLAHS/David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Alborz ZinabadiDivision of General Surgery, Department of Surgery, VAGLAHS/David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Saroj K BasakDepartment of Medicine, VAGLAHS/David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Kislay ParvatiyarDepartment of Microbiology, Immunology and Molecular Genetics, UCLA, Los Angeles, California, USA.
Meera SrivastavaDepartment of Anatomy, Physiology and Genetics and Institute of Molecular Medicine, Uniformed Services University of Health Services School of Medicine, Bethesda, Maryland, USA.
Li-Jung LiangDepartment of Medicine, VAGLAHS/David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
David W GjertsonDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Jorge Z TorresDepartment of Chemistry and Biochemistry, UCLA, Los Angeles, California, USA.
Neda A MoatamedDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Eri S SrivatsanDivision of General Surgery, Department of Surgery, VAGLAHS/David Geffen School of Medicine at UCLA, Los Angeles, California, USA Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, USA esrivats@g.ucla.edu.
University of California, Los Angeles · USVA Greater Los Angeles Healthcare System · USUniformed Services University of the Health Sciences · USVA West Los Angeles Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We and others have shown that the cystatin E/M gene is inactivated in primary human tumors, pointing to its role as a tumor suppressor gene. However, the molecular mechanism of tumor suppression is not yet understood. Using plasmid-directed cystatin E/M gene overexpression, a lentivirus-mediated tetracycline-inducible vector system, and human papillomavirus 16 (HPV 16) E6 and E7 gene-immortalized normal human epidermal keratinocytes, we demonstrated intracellular and non-cell-autonomous apoptotic growth inhibition of tumor cell lines and that growth inhibition is associated with cytoplasmic retention of NF-κB. We further demonstrated decreased phosphorylation of IκB kinase (IKKβ) and IκBα in the presence of tumor necrosis factor alpha (TNF-α), confirming the role of cystatin E/M in the regulation of the NF-κB signaling pathway. Growth suppression of nude mouse xenograft tumors carrying a tetracycline-inducible vector system was observed with the addition of doxycycline in drinking water, confirming that the cystatin E/M gene is a tumor suppressor gene. Finally, immunohistochemical analyses of cervical carcinoma in situ and primary tumors have shown a statistically significant inverse relationship between the expression of cystatin E/M and cathepsin L and a direct relationship between the loss of cystatin E/M expression and nuclear expression of NF-κB. We therefore propose that the cystatin E/M suppressor gene plays an important role in the regulation of NF-κB.

Indexed as

AnimalsCathepsin LCell Line, TumorCell ProliferationCystatin MCytoplasmDoxycyclineFemaleGene Expression Regulation, NeoplasticGenetic VectorsHeLa CellsHumansI-kappa B ProteinsLentivirusMiceMice, NudeCathepsin LCST6 protein, humanCTSL protein, humanCystatin MDoxycyclineI-kappa B ProteinsNF-kappa BTNF protein, humanTumor Necrosis Factor-alpha

Identifiers

PMID27090639
PMCPMC4907098
OpenAlexW2342062812

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.